<DOC>
	<DOC>NCT00212680</DOC>
	<brief_summary>The purpose of this study was to evaluate the dose-dependent effects of ONO-1101 on efficacy and safety in patients with postoperative supraventricular tachyarrhythmias.</brief_summary>
	<brief_title>Controlled Study of ONO-1101 in Patients With Postoperative Tachyarrhythmias in Japan</brief_title>
	<detailed_description />
	<mesh_term>Tachycardia</mesh_term>
	<mesh_term>Landiolol</mesh_term>
	<criteria>1. 2080 years old 2. Postoperative supraventricular tachyarrhythmias (sinus tachycardia, those with a heart rate of 120 beats/min or higher, and supraventricular arrhythmia, those with a heart rate of 100 beats/min or higher) 3. Within 7 days postoperatively 4. Other inclusion criteria as specified in the protocol 1. Acute myocardial infarction (within 1 month after onset) 2. Severe heart failure (New York Heart Association functional class III or higher) 3. Atrioventricular block (grade II or higher),or sick sinus syndrome 4. Other exclusion criteria as specified in the protocol</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>ONO-1101,Landiolol Hydrochloride, Postoperative, Supraventricular Tachyarrhythmia</keyword>
</DOC>